Most guidelines recommend high-intensity statins for the secondary prevention of acute coronary syndrome (ACS). However, several studies from other Asian populations suggest enhanced sensitivity to statins, with effective low-density lipoprotein cholesterol (LDL-C) reduction seen at lower doses and possible higher incidence of adverse effects at higher statin doses. However, there is no published data from Sri Lanka. Therefore, we aimed to explore this hypothesis by comparing the efficacy, safety and cost-effectiveness of atorvastatin at doses of 40 mg and 80 mg in a cohort of South Asian individuals presenting with ACS from Sri Lanka. This single-centre, prospective, randomised, controlled, open-label clinical trial is being conducted among patients naïve for statins admitted with incident ACS to a tertiary care setting in Sri Lanka. All patients will have LDL-C measured at baseline and are randomised to receive atorvastatin 40 mg or 80 mg in addition to standard of care. Data are collected using an interviewer-administered proforma. Patients are evaluated at 6, 12 and 24 weeks for adverse drug reactions and LDL-C level. The primary endpoint is the percentage of patients achieving LDL-C ≤ 70 mg/dL at 12 weeks. This outcome will be analysed by the intention-to-treat analysis. Secondary outcomes include safety assessments and a cost-effectiveness evaluation. For the latter, data on medication costs, including the number of tablets consumed, will be collected to calculate the average cost-effectiveness ratio and incremental cost-effectiveness ratio between the two dosing regimens. This will be the first head-to-head comparison of atorvastatin 40 mg and 80 mg in a South Asian cohort. The findings will provide evidence on efficacy and safety of prescribing atorvastatin 40 mg dose in South Asians with ACS. Sri Lanka Clinical Trial Registry, SLCTR/2023/003. Registered on 03 March 2023, https://slctr.lk/trials/slctr-2023-003 .
Introduction Acalypha indica (AI) is an Ayurvedic medicinal plant. Some of this plant’s phytochemicals have been reported to cause oxidative stress in red blood cells. However, we know very little about those chemicals due to a dearth of literature. We present a case in which a patient with a previously unidentified glucose-6-phosphate dehydrogenase (G6PD) deficiency experienced acute hemolysis after ingesting fresh AI plant leaves. Case Presentation A 65-year-old man presented with jaundice, pallor, and haematuria following ingestion of the "Kuppamenia mallum" dish. His peripheral blood picture showed bite cells and Heinz bodies. A positive Brewer's test raised the clinical suspicion of G6PD deficiency. Low values of the G6PD level assessment at the follow-up visit confirmed the diagnosis. Conclusion Although AI is regarded as a medicinal plant, acute hemolysis can also occur after consumption in G6PD-deficient patients. This case emphasises the need for further research to identify the phytochemicals and their concentrations that can induce toxicity.
Early and accurate diagnosis of diabetes is essential to prevent long-term complications. While the oral glucose tolerance test (OGTT) is the reference sta
Introduction: Dyslipidaemia is an important risk factor for cardiovascular diseases(CVD) and optimal management helps prevent CVD burden in a country. Knowledge of medical officers(MOs) on dyslipidaemia management is critical in this regard. We assessed knowledge and adherence of MOs of Gampaha district to the National Institute of Clinical Excellence (NICE) guideline 2020 on management of dyslipidaemia. Methods: We conducted a cross-sectional study at five secondary/tertiary-care hospitals in Gampaha District in January 2022. Knowledge and adherence were studied using a self-administered questionnaire consisting of 25 multiple-choice questions. Each question was scored "1" and the cumulative score was converted to 100. A score >80 was considered "good knowledge and adherence" and its associations were studied using logistic regression.Results: A total of 413 MOs (63.4% females, mean age 45±7.6 years) participated in the study. Of them, 73.1% had worked in a medical ward previously. The mean knowledge and adherence score was 77±9.3. Only 30% had a score >80. Good knowledge and adherence was significantly associated with being <45 years (p .004) in age, having work experience in a medical ward (p<.001), having post-graduate training (p<.001), working in a tertiary care hospital(p=.007), and involved in private practice(p=.002). There was no significant association with attendance at continuing medical education programmes (p=.320) or the duration of service(p=.120).Conclusions: Only a third of MOs of Gampaha district had good Knowledge and adherence to NICE-2020 dyslipidaemia guidelines. Knowledge and adherence to the guideline was better in MOs who are young, in postgraduate training, with previous experience in medical wards, working in tertiary care hospitals or engaged in private practice.
Introduction: The high-sensitivity cardiac troponin (hs-cTn) assay is a crucial diagnostic test that is obligatory in the triage of patients presenting with chest pain. It is essential for medical officers to have adequate knowledge regarding the procedures for testing and the interpretation of test outcomes to deliver optimal healthcare for patients. It has been observed that medical officers are lacking in awareness regarding this testing method, resulting in a greater likelihood of errors in testing and interpretation. This study aims to evaluate the level of understanding among medical officers regarding the hs-cTn assay in relation to the most recent European Society of Cardiology guideline released in 2020.Methodology: We conducted a cross-sectional study at two government hospitals in Gampaha District in June 2022. A self-administered e-questionnaire was used to assess knowledge regarding hs-cTn. Knowledge was measured by calculating a cumulative score for the answers to a questionnaire and categorised into good or poor knowledge. A score less than 60% was categorized as poor and vice versa. Descriptive statistics were used to summarize the data.Results: Of the 227 medical officers, only 14.5% (n=33) had good knowledge of the analytical component while 41.9% (n=95) had good knowledge on the clinical component. A score ≥60% on the analytical component knowledge was significantly associated with designation being a senior registrar or consultant (p<0.001), postgraduate enrolment (p<0.001), participation in continuous professional development programmes (p<0.001), and employment in a teaching hospital (p=0.025), but not with age (p=0.066) or private practice (p=0.118). Clinical component knowledge score ≥60% was significantly associated with age between 25 and 35 years (p=0.006), designation being a consultant (p<0.001), postgraduate enrolment (p<0.001), participation in continuous professional development programs (p<0.001), and employment in a teaching hospital(p=0.001) but not with doing private practice (p=0.170).Conclusions: In Sri Lanka, medical officers’ general knowledge on the hs-cTn assay seems lacking. There is a need for continuous training to improve knowledge on hs-cTn testing among medical officers.